OVERVIEW
HIV-1 entry and how to block it
The HIV-1 assembly machine
Recent advances in the understanding of HIV accessory protein function
Mechanisms of HIV-1 drug resistance
Infection with HIV-2
OVERVIEW
Epidemiological considerations in planning HIV preventive vaccine trials
The public health significance of HIV-1 subtypes
Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia: experiences and recommendations
Access and activism: the ethics of providing antiretroviral therapy in developing countries
The epidemics of injecting drug use and HIV in Asia
OVERVIEW
New insights into protective humoral responses and HIV vaccines
New insights into evaluating effective T-cell responses to HIV
Innate immunity and HIV
Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?
The HIV vaccine pipeline, from preclinical to phase III
OVERVIEW
Alternative strategies for anti-HIV treatment
Therapeutic drug monitoring as a tool in treating HIV infection
Cytokine-based therapies for HIV infection
Highly active antiretroviral therapy and coronary heart disease: the need for perspective
Issues in the treatment of Mycobacterium tuberculosis in patients with human immunodeficiency virus infection